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antigen in urine, which shows a sensitivity of 68 100% and
speciﬁcity of 100% in beginning trials.
Conclusion: Our research is centralized to develop a
detection method either from isolated speciﬁc antigen or
from serum or any other ﬂuid / tissues taken from kala-
azar patients, which is easy to carry out and efﬁcient
for the diagnosis of visceral leishmaniais in ﬁeld as well
as in laboratory condition where lack of sophisticated
instruments and expertise persons.
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Introduction: HCC is the 6th common cancer. Global increase
of hepatitis B and C infection, the incidence of HCC has
been steadily increasing. Egypt seroprevalence of HCV in
Nile delta was 20 35%. AFP had limited sensitivity 60% and
speciﬁcity 90% for small HCC. GPC-3 oncofetal protein over
expressed in HCC.
Aim: Evaluating the validity of Glypican-3 as an early
detector of HCC.
Material: 10 healthy controls and 40 HCV positive patients:
10 patients with chronic hepatitis C virus infection,
10 patients with compensated cirrhosis [Child Pugh class
A and B], 10 patients with decompensated cirrhosis
[Child Pugh class C], 10 patients with HCC.
Methods: Liver functions: ALT, AST, Bilirubin (T), Albumin,
gGT. Tumor markers: AFP and GPC-3.Viral markers: HCV
antibodies, HBs Ag and HBc Ab.
Results: The median value of GPC-3 in HCC, DC, CC
was signiﬁcantly higher than chronic hepatitis and control
groups. No signiﬁcant correlation found between AFP and
GPC-3. AUROC of AFP was 0.85 & AUROC of GPC-3 was 0.84.
The diagnostic sensitivity of AFP (20 ng/ml) was 70% with
PPV 53.8%. The speciﬁcity was 85% with NPV 91.9%. While
the diagnostic Sensitivity of GPC-3 (2 ng/ml) was 100% with
PPV 27%. The speciﬁcity was 42.2% with NPV 100%. Combined
serial approach of AFP and GPC-3 improved the speciﬁcity
to 87.5%.
Conclusion: GPC-3 although it is a serological test for early
detection of HCC, it showed limited speciﬁcity, where It
is detected in different stages of chronic liver disease, as
it is an oncofetal protein produced by regenerating liver
cells. The diagnostic signature approach for simultaneous
determination of AFP and GPC-3 may improve the prediction
accuracy of HCC patients in those showing seronegativity to
AFP.
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Egypt has one of the highest incidence of liver diseases in
the world with prevalence of schistosomiasis. NO diffuses
into cytosol of adjacent vascular smooth muscle cells play
a role in the pathogenesis of vasodilation. Endothelial
cells also produce the most potent vasoconstrictor agent
endothelin (ET-1).
Aim: Evaluation of nitric oxide and endothelin-1 and
procollagen III peptide in patients with chronic liver disease
and portal hypertension in both systemic and portal blood
samples together with the histopathological scoring of liver
biopsies.
Subjects: The control group 15 subjects free from any liver
disease. The patient group 30 patients with chronic liver
disease and schistosomal portal hypertension.
Methods: Clinical examination, abdominal ultrasonography,
measurement of portal venous pressure and histopatholog-
ical examination of liver biopsy. Laboratory investigations
included evaluation of total nitric oxide (NO), endothelin-1
(Et-1) and type III procollagen (PIIINP) in both portal
and systemic blood. In addition prothrombin, serum
alanine, aspartate aminotransferase (AST, ALT), g glutamyl
aminotransferase (gGT) activities, serum bilirubin, albumin,
serodetection of hepatitis B surface antigen (HBsAg) and
hepatitis B core antibody and (anti-HCVAb).
Results:
• NO and ET-1 levels in both systemic and portal blood of
SHF patients were signiﬁcantly higher than in the control
group.
• NO is a potent vasodilator.
• ET-1 increase may be a compensatory mechanism to
antagonize the vasodilatory effect of NO.
• Child class B subgroup had higher NO and ET-1 than
class A.
• NO and ET-1 levels did not differ between anti HCV
positive and negative SHF patients.
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Objectives: Three species or subspecies of spotted fever
group rickettsiae (SFRG) were documented in China.
Recently, we detected a novel serotyping SFRG which
was broadly prevalence in China. However, the greatest
challenge in preventing and controlling rickettsiosis in China
is laboratory diagnosis. Few clinical laboratories have the
laboratory diagnostic ability for rickettisae and even some
better equipped laboratories also used old Weil Felix. In
order to solve this problem, our national laboratory for
rickettsiosis surveillance has developed a Taqman real-time
PCR assay based on the SFGR ompA gene that was devised
for rapid detection of SFRG.
Methods: The primers and probes for the real-time PCR
were designed based on the conserved sequences of the
ompA gene through alignment from 14 SFGR species. Two
hundred and sixty ﬁve blood samples (127 goats, 78 dogs, 60
cattle) collected from Yunnan Provinces were tested using
the developed PCR to investigate the infection rate and the
distribution among these animals.
Results: The developed assay ampliﬁed most of the SFGR
strains: R. sibirica, R. conorii, R. marmionii, R. rickettsii,
R. africa, R. parkeri, R. canada, R. heilongjiangensis but not
R. akari and R. felisi. Genomic DNA from other members of
the order Rickettsiales showed negative results. The mean
(range) CV values for intra-assay and interassay variation
were 1.15% and 2.59% respectively. The limits of detection
(LOD) was 200 copies per reaction. Of the 265 animal blood
samples, 56 (21.13%) tested positive. The prevalence among
